Drug recall · November 5, 2014
"NB2014" 30 mg/6 mg/300 mcg/0.3 mg/mL recall
Why: Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
"NB2014" 30 mg/6 mg/300 mcg/0.3 mg/mL (phentolamine mesylate, papaverine, alprostadil, atropine) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
- Lots / codes
Lot Number: 07152014@52, Exp 9/30/2014; 07202014@7, Exp 10/18/2014
- Quantity
- 85 mL
- Company
- Martin Avenue Pharmacy, Inc., Naperville, IL
- Distribution
- Nationwide
- Initiated
- August 27, 2014 · Voluntary: Firm initiated
- Classified
- October 29, 2014
- Reported
- November 5, 2014
- Ended
- May 31, 2018
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atropine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.